Reneo Pharmaceuticals Price on September 18, 2024

RPHMDelisted Stock  USD 18.20  1.40  8.33%   
If you're considering investing in Reneo Stock, it is important to understand the factors that can impact its price. As of today, the current price of Reneo Pharmaceuticals stands at 18.20, as last reported on the 26th of December, with the highest price reaching 19.00 and the lowest price hitting 16.80 during the day. Reneo Pharmaceuticals is somewhat reliable given 3 months investment horizon. Reneo Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.45, which implies the firm had a 0.45% return per unit of risk over the last 3 months. We have analyze and collected data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.36% are justified by taking the suggested risk. Use Reneo Pharmaceuticals Risk Adjusted Performance of 0.0897, coefficient of variation of 973.22, and Semi Deviation of 2.63 to evaluate company specific risk that cannot be diversified away.
  
Reneo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.446

Best PortfolioBest Equity
Good Returns
Average ReturnsRPHM
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.06
  actual daily
27
73% of assets are more volatile

Expected Return

 1.36
  actual daily
27
73% of assets have higher returns

Risk-Adjusted Return

 0.45
  actual daily
35
65% of assets perform better
Based on monthly moving average Reneo Pharmaceuticals is performing at about 35% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Reneo Pharmaceuticals by adding it to a well-diversified portfolio.

Related Headline

Hepion Pharmaceuticals Headline on 18th of September 2024

Hepion Pharmaceuticals, Inc. saw a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 75,700 shares, a decrease of 6.8 percent from the August 15th total of 81,200 shares. Based on an average daily volume of 151,400 shares, the days-to-cover ratio

Reneo Pharmaceuticals Valuation on September 18, 2024

It is possible to determine the worth of Reneo Pharmaceuticals on a given historical date. On September 18, 2024 Reneo was worth 13.5 at the beginning of the trading date compared to the closed value of 15.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Reneo Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Reneo Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Reneo Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Reneo Pharmaceuticals' related companies.
 Open High Low Close Volume
  13.80    14.10    12.70    13.90    23,475  
09/18/2024
  13.50    15.70    13.50    15.00    73,323  
  15.00    15.50    14.10    15.10    61,429  
Backtest Reneo Pharmaceuticals  |  Reneo Pharmaceuticals History  |  Reneo Pharmaceuticals Valuation   PreviousNext  
Open Value
13.5
15.0
Closing Value
22.67
Upside

Reneo Pharmaceuticals Trading Date Momentum on September 18, 2024

On September 19 2024 Reneo Pharmaceuticals was traded for  15.10  at the closing time. The top price for the day was 15.50  and the lowest listed price was  14.10 . The trading volume for the day was 61.4 K. The trading history from September 19, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 0.67% . The trading delta at closing time against the current closing price is 11.33% .

Reneo Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Reneo Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Reneo Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Reneo financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Reneo Pharmaceuticals Stock history

Reneo Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Reneo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Reneo Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Reneo Pharmaceuticals stock prices may prove useful in developing a viable investing in Reneo Pharmaceuticals
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company was incorporated in 2014 and is headquartered in Irvine, California. Reneo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.

Reneo Pharmaceuticals Stock Technical Analysis

Reneo Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Reneo Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Reneo Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Reneo Pharmaceuticals Period Price Range

Low
December 26, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Reneo Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Reneo Pharmaceuticals December 26, 2024 Market Strength

Market strength indicators help investors to evaluate how Reneo Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reneo Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reneo Pharmaceuticals stock market strength indicators, traders can identify Reneo Pharmaceuticals entry and exit signals to maximize returns

Reneo Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Reneo Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Reneo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Reneo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in Reneo Stock

If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Transaction History
View history of all your transactions and understand their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk